Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 337 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parent Child Relationship Clear all

Conditions: Melanoma (Skin)
Interventions: NY-ESO-1 157-165 (165V), Nivolumab, gp100:280-288 (288V), Montanide ISA 51 vegetable grade (VG), Ipilimumab, Apheresis Procedure; Biological · Drug · Procedure
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 16 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2023
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Traumatic Brain Injury
Interventions: Positive Parenting Intervention; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 0 Years to 4 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Depression
Interventions: Parent Child Interaction Therapy-Emotion Development (PCIT-ED), Developmental Education Parenting Intervention (DEPI); Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 3 Years to 6 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Anxiety
Interventions: Psycho-social, computerized intervention targeting error sensitivity; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 5 Years to 7 Years
Enrollment: 222 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Cerebral Small Vessel Diseases, Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy, Cerebral Microbleeding, Sporadic White Matter Disease
Interventions: Cilostazol; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2030
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Bipolar Disorder
Interventions: Not listed
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Unspecified Child Maltreatment, Suspected, Unspecified Child Maltreatment, Confirmed
Interventions: Durham Connects; Other
Lead sponsor: Duke University; Other
Eligibility: Up to 6 Months
Enrollment: 1,650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Substance Abuse, Child Abuse, Child Neglect
Interventions: Comprehensive Community Treatment, MST-BSF; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 6 Years and older
Enrollment: 191 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: New Britain, Connecticut

Conditions: Childhood Mental Disorder
Interventions: PCIT-ED, Parenting Wisely; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 48 Months to 83 Months
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Diabetes Mellitus, Type 2
Interventions: IcoSema, Insulin glargine, insulin aspart; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 679 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 66
States / cities: Guntersville, Alabama • Fresno, California • La Jolla, California + 59 more

Conditions: Pediatric Obesity
Interventions: DRIVE Program; Behavioral
Lead sponsor: Georgia State University; Other
Eligibility: 2 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Atlanta, Georgia • Baton Rouge, Louisiana

Conditions: COVID-19, Sars-CoV-2 Infection
Interventions: Sky Medical™ Rapid Antigen Test; Diagnostic Test
Lead sponsor: Sky Medical Supplies & Equipments, LLC; Industry
Eligibility: 7 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Lake Worth, Florida

Conditions: Pharmacokinetics of ASP015K, Bioavailability of ASP015K, Healthy Subjects
Interventions: ASP015K; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Glendale, California

Conditions: Parenting Behaviors and PTSD Symptoms
Interventions: SAHP; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Austin, Texas • Temple, Texas • Waco, Texas

Conditions: Disability Physical, Wheelchair, Obesity; Overweight
Interventions: The Fast In-Bed Tracking System (FIT) Weight Scale, Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) intervention; Device · Behavioral
Lead sponsor: Jonathan Pearlman; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Language Delay, Substance Use Disorders, Language Disorders in Children, Language Development, Prevention Intervention
Interventions: Comilia Group, Interaction Review Enhancement, Practical Support Enhancement; Behavioral
Lead sponsor: University of Oregon; Other
Eligibility: 18 Years and older
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Traumatic Brain Injury, Disruptive Behavior
Interventions: PCIT; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 2 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Behavioral Health
Interventions: Episodic Future Thinking; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: Not listed
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Postpartum Depression, Parenting, Parent-Child Relations
Interventions: Social Media-Based Parenting Program, MoodGym; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 18 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Child Externalizing Behavior
Interventions: Helping the Noncompliant Child (HNC), Technology-Enhanced Helping the Noncompliant Child (TE-HNC); Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 3 Years to 8 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Substance-Related Disorders
Interventions: BRIGHT, STAR/TAU+; Behavioral · Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Post-Traumatic Stress Disorder
Interventions: Interactive Healthcare Communication Application, Control Web sites; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Substance Use Disorder (SUD), Rural Health, Family Resilience, Child Maltreatment, Child Well-beiing, Substance Use Recovery
Interventions: Ohio START (Ohio Sobriety, Treatment, and Reducing Trauma); Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: AChR-Ab Seropositive Generalized Myasthenia Gravis, Myasthenia Gravis, MG, gMG, Generalized Myasthenia Gravis, Generalized Myasthenia Gravis (gMG)
Interventions: Efgartigimod IV, Empasiprubart IV; Biological
Lead sponsor: argenx; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 14
States / cities: Carlsbad, California • Miami, Florida • Tampa, Florida + 11 more

Search by objective public record fields.

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Gaining Real-Life Skills Over the Web

Effectiveness of Parent-Child Interaction and Emotion Development Therapy in Treating Preschool Children With Depression

Targeting the ERN Computerized Intervention Targeting the Error-related Negativity in Young Children

Retina is a Marker for Cerebrovascular Heath

Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a Child

Durham Connects RCT Evaluation II

Family-Based Treatment for Parental Substance Abuse and Child Maltreatment

Trial of PCIT-ED in School for Preschoolers in Poverty

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

Development of the DRIVE Curriculum to Address Childhood Obesity Risk Factors

This Trial is a Clinical Performance Validation Study That Will Evaluate the Clinical Agreement of the Sky Medical™ Rapid Antigen Test Comparing the Antigen Rapid Test to RT-PCR

A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New Formulation

Parenting Strength At Home- Parents Pilot

Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Complete a Weight Loss Program, Half Get Scales at Baseline, Half at Month 6 Those Who Receive the Bed Scales at Baseline Are Expected to Have Increased Weight Loss

Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services

Parent-Child Interaction Therapy (PCIT) for Children With Traumatic Brain Injury (TBI): A Stepped-Care Model

Improving Delay Discounting to Decrease Harsh Parenting Among Parents Receiving Substance Use Treatment

Social Media-Based Parenting Program for Women With Postpartum Depressive Symptoms

Technology-Enhanced Helping the Noncompliant Child

Growing Together: Women in Opioid Treatment and Their Infants

Effectiveness of a Web-based Intervention for Guardians of Children Whose One Parent Has Murdered the Other

Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod